is toujeo a glp-1 Proven A1C Reduction Toujeo® U-300 (insulin glargine) injection

This is why Tirzepatide (Mounjaro/Zepbound), which combines GLP-1 and GIP, produces better results than Semaglutide alone while causing less nausea (25% versus 44%)

Although the primary endpoint was not significantly improved by duloxetine compared to placebo, treatment with duloxetine was associated with an improvement in secondary endpoints, including analgesia and quality of life

The patient's vital signs were stable: blood pressure was 142/82 mm Hg, heart rate was 80 bpm, respiratory rate was 16 breaths/min, and oxygen saturation was 100% on room air

Climate Change 2013: The Physical Science Basis (Cambridge University Press, Cambridge, UK, and New York, 2013)

Another important feature of type 1 diabetes is the presence of insulin resistance